Explore >> Select a destination
|
You are here 
|
www.cardiobrief.org | ||
| | | | |
www.detroitnews.com
|
|
| | | | | Novo Nordisk A/S's blockbuster diabetes drug Ozempic cut patients' risk of dying in a kidney-disease study, the latest research pointing to the medicine's usefulness in a constellation of disorders. | |
| | | | |
www.cureffi.org
|
|
| | | | | 20 years after the discovery of RNA interference, the first drug is approved. Great news, but our path forward for prion disease remains unchanged. | |
| | | | |
blog.philbirnbaum.com
|
|
| | | | | ||
| | | | |
www.livescience.com
|
|
| | | CRISPR is a versatile tool for editing genomes and has recently been approved as a gene therapy treatment for certain blood disorders. | ||
